Comparing Semaglutide vs Liraglutide for UK Weight Loss: Which One is Right for You?

By Dr. Emma Richardson

Hey there! If you’re exploring weight loss options in the UK, chances are you’ve heard about Semaglutide and Liraglutide. Both medications have gained serious attention for their role in helping people shed pounds, but what’s the real difference? As a doctor who’s worked closely with patients using these treatments, I want to break it down for you in a straightforward, no-nonsense way.

What Are Semaglutide and Liraglutide?

Both Semaglutide and Liraglutide belong to a class of drugs called GLP-1 receptor agonists. Originally developed to treat type 2 diabetes, these medications have shown remarkable effects on appetite suppression and weight loss.

Semaglutide is marketed under names like Ozempic and Wegovy, whereas Liraglutide is known as Saxenda for weight management and Victoza for diabetes. In the UK, they’re prescribed under medical supervision, often alongside lifestyle changes for the best results.

How Do They Work?

Both drugs mimic a hormone called glucagon-like peptide-1 (GLP-1) that helps regulate appetite and calorie intake. They slow down stomach emptying, increase feelings of fullness, and reduce hunger. However, Semaglutide generally has a longer half-life allowing once-weekly dosing, while Liraglutide requires daily injections.

Effectiveness for Weight Loss: Semaglutide vs Liraglutide

Clinical studies point to some clear differences:

• Semaglutide: In a landmark study published in The New England Journal of Medicine, participants lost an average of 15-17% of their body weight over 68 weeks with Semaglutide 2.4 mg weekly injections (Wilding et al., 2021).
• Liraglutide: The SCALE trial showed that daily injections of Liraglutide 3.0 mg led to an average weight loss of around 8% after 56 weeks (Pi-Sunyer et al., 2015).

Clearly, Semaglutide demonstrates significantly higher average weight loss compared to Liraglutide.

Side Effects and Safety

Both medications share common side effects such as nausea, vomiting, and diarrhea, especially during the initial weeks. These tend to subside as your body adjusts. Rarely, more serious gastrointestinal or pancreatic effects have been reported, so close medical supervision is essential.

In the UK, the NHS and MHRA monitor safety profiles closely. For example, NHS guidance on Semaglutide advises regular follow-ups with your healthcare provider during treatment.

Convenience and Dosing

One big plus for Semaglutide is the once-weekly injection, which many patients find easier to incorporate into their routines compared to the daily injections needed for Liraglutide. This can improve adherence and overall satisfaction.

Cost Considerations in the UK

Both drugs are prescription-only and not typically available on the NHS for weight loss, meaning you’ll likely purchase them privately. Prices vary, but Semaglutide can be more cost-effective due to less frequent dosing.

Summary Comparison Table

Which One Should You Choose?

Deciding between Semaglutide and Liraglutide comes down to your lifestyle, preferences, and medical history. Many patients prefer Semaglutide due to the higher weight loss results and easier weekly dosing. But some may tolerate Liraglutide better or find daily dosing suits their routine.

Always consult your GP or a specialist to discuss these options. These drugs are tools—not magic bullets—and work best when combined with healthy eating and exercise.

Ready to Take the Next Step?

Interested in exploring Semaglutide for your weight loss journey? Order your consultation today with trusted UK providers and get started safely.

Prefer to learn more about medication options? Contact our expert team for personalised guidance and support.

FAQ